Brief: Dermata Therapeutics Announces Strategic Pivot To OTC Skin Care - SEC Filing
14/11/2025 21:20
Nov 14 (Reuters) - Dermata Therapeutics Inc DRMA.O: DERMATA THERAPEUTICS INC - ANNOUNCES STRATEGIC PIVOT TO OTC SKIN CARE - SEC FILING DERMATA THERAPEUTICS INC - TO LAUNCH FIRST OTC ACNE KIT MID-2026 - SEC FILING Source text: [ID:n0001493152-25-023419] Further company coverage: DRMA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dermata Therapeutics
See all newsNASDAQ RESUMED AT 10:31 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM
Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026
Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dermata Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview